ALGN vs. CRL
ALGN (Align Technology, Inc.) and CRL (Charles River Laboratories International, Inc.) are both stocks. Both are in the Healthcare sector — ALGN in Medical Devices, CRL in Diagnostics & Research. Over the past 10 years, ALGN returned 8.12%/yr vs 8.21%/yr for CRL. At a 0.37 correlation, their price movements are largely independent.
Performance
ALGN vs. CRL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ALGN achieves a 10.18% return, which is significantly higher than CRL's -6.54% return. Both investments have delivered pretty close results over the past 10 years, with ALGN having a 8.12% annualized return and CRL not far ahead at 8.21%.
ALGN
- 1D
- 2.57%
- 1M
- 1.94%
- YTD
- 10.18%
- 6M
- 9.11%
- 1Y
- -4.74%
- 3Y*
- -17.32%
- 5Y*
- -21.72%
- 10Y*
- 8.12%
CRL
- 1D
- 2.81%
- 1M
- 4.97%
- YTD
- -6.54%
- 6M
- -0.36%
- 1Y
- 28.85%
- 3Y*
- -1.93%
- 5Y*
- -11.63%
- 10Y*
- 8.21%
ALGN vs. CRL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ALGN Align Technology, Inc. | 10.18% | -25.11% | -23.90% | 29.92% | -67.91% | 22.98% | 91.51% | 33.24% | -5.74% | 131.13% |
CRL Charles River Laboratories International, Inc. | -6.54% | 8.06% | -21.91% | 8.49% | -42.17% | 50.80% | 63.56% | 34.97% | 3.41% | 43.65% |
Correlation
The correlation between ALGN and CRL is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.44 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.43 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.50 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.49 |
Correlation (All Time) Calculated using the full available price history since Jan 31, 2001 | 0.37 |
The correlation between ALGN and CRL shifts across timeframes, from 0.37 (all time) to 0.50 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
ALGN:
$12.32B
CRL:
$9.13B
ALGN:
$5.96
CRL:
-$3.75
ALGN:
3.03
CRL:
2.28
ALGN:
2.97
CRL:
3.10
ALGN:
$4.10B
CRL:
$4.03B
ALGN:
$2.77B
CRL:
$1.00B
ALGN:
$776.15M
CRL:
$737.05M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ALGN vs. CRL — Risk / Return Rank
ALGN
CRL
ALGN vs. CRL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Align Technology, Inc. (ALGN) and Charles River Laboratories International, Inc. (CRL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ALGN | CRL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.73 | ||
| Sortino ratioReturn per unit of downside risk | -0.88 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 1.15 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | -0.12 | 0.86 | -0.98 |
| Martin ratioReturn relative to average drawdown | -0.20 | 1.77 | -1.97 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ALGN | CRL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.09 | 0.64 | -0.73 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.44 | -0.27 | -0.17 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.17 | 0.22 | -0.05 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.16 | 0.24 | -0.08 |
Drawdowns
ALGN vs. CRL - Drawdown Comparison
The maximum ALGN drawdown since its inception was -92.30%, which is greater than CRL's maximum drawdown of -78.23%. Use the drawdown chart below to compare losses from any high point for ALGN and CRL.
Loading charts...
Drawdown Indicators
| ALGN | CRL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.30% | -78.23% | -14.07% |
Max Drawdown (1Y)Largest decline over 1 year | -39.73% | -33.88% | -5.85% |
Max Drawdown (3Y)Largest decline over 3 years | -67.59% | -63.52% | -4.07% |
Max Drawdown (5Y)Largest decline over 5 years | -82.89% | -78.23% | -4.66% |
Max Drawdown (10Y)Largest decline over 10 years | -82.89% | -78.23% | -4.66% |
Current DrawdownCurrent decline from peak | -76.43% | -59.32% | -17.11% |
Average DrawdownAverage peak-to-trough decline | -37.65% | -25.73% | -11.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.90% | 16.36% | +7.54% |
Volatility
ALGN vs. CRL - Volatility Comparison
The current volatility for Align Technology, Inc. (ALGN) is 11.85%, while Charles River Laboratories International, Inc. (CRL) has a volatility of 16.68%. This indicates that ALGN experiences smaller price fluctuations and is considered to be less risky than CRL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ALGN | CRL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.85% | 16.68% | -4.83% |
Volatility (6M)Calculated over the trailing 6-month period | 28.46% | 34.88% | -6.42% |
Volatility (1Y)Calculated over the trailing 1-year period | 52.81% | 45.06% | +7.75% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 49.56% | 42.76% | +6.80% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.06% | 37.78% | +11.28% |
Dividends
ALGN vs. CRL - Dividend Comparison
Neither ALGN nor CRL has paid dividends to shareholders.
Financials
ALGN vs. CRL - Financials Comparison
This section allows you to compare key financial metrics between Align Technology, Inc. and Charles River Laboratories International, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ALGN vs. CRL - Profitability Comparison
ALGN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Align Technology, Inc. reported a gross profit of 736.59M and revenue of 1.04B. Therefore, the gross margin over that period was 70.8%.
CRL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Charles River Laboratories International, Inc. reported a gross profit of 0.00 and revenue of 995.83M. Therefore, the gross margin over that period was 0.0%.
ALGN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Align Technology, Inc. reported an operating income of 141.96M and revenue of 1.04B, resulting in an operating margin of 13.7%.
CRL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Charles River Laboratories International, Inc. reported an operating income of 119.90M and revenue of 995.83M, resulting in an operating margin of 12.0%.
ALGN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Align Technology, Inc. reported a net income of 112.77M and revenue of 1.04B, resulting in a net margin of 10.8%.
CRL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Charles River Laboratories International, Inc. reported a net income of -14.84M and revenue of 995.83M, resulting in a net margin of -1.5%.
Frequently Asked Questions
ALGN and CRL have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRL has higher volatility (16.68%) compared to ALGN (11.85%). In terms of maximum drawdown, ALGN dropped -92.30% vs CRL's -78.23%.
CRL currently has the higher Sharpe Ratio (0.64 vs -0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ALGN and CRL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer